KI-Beratung Beta

  • Produktbild: Quantitative Drug Safety and Benefit Risk Evaluation
  • Produktbild: Quantitative Drug Safety and Benefit Risk Evaluation

Quantitative Drug Safety and Benefit Risk Evaluation Practical and Cross-Disciplinary Approaches

76,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.01.2024

Abbildungen

33 SW-Abb., 6 SW-Fotos, 27 SW-Zeichn., 28 Tabellen

Herausgeber

William Wang + weitere

Verlag

Taylor & Francis

Seitenzahl

404

Maße (L/B/H)

23,4/15,6/2,2 cm

Gewicht

611 g

Sprache

Englisch

ISBN

978-1-03-219111-9

Beschreibung

Rezension

"This is an amazing book for anyone working in the clinical research industry and does not require at all extensive knowledge of statistics or prior exposure to statistics at all. In fact, I would say that the target audience is broader than just statisticians but including instead everyone working in the clinical research industry involved in study planning, analysis and/or reporting."

- David Manteigas, ISCB News, September 2022.

"Overall, this book provides thorough background andknowledge about clinical considerations and regulatory policies, as well as a comprehensive review of frequently used safety-specific statistical methods with clear and thoughtful explanations... Therefore, I strongly recommend this book to all who eithe ralready work on clinical studies or who are new to the area and are interested in clinical trial planning and analyses."

- Huan Wang, The American Statistician, January 2023.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.01.2024

Abbildungen

33 SW-Abb., 6 SW-Fotos, 27 SW-Zeichn., 28 Tabellen

Herausgeber

Verlag

Taylor & Francis

Seitenzahl

404

Maße (L/B/H)

23,4/15,6/2,2 cm

Gewicht

611 g

Sprache

Englisch

ISBN

978-1-03-219111-9

Herstelleradresse

Produktsicherheitsverantwortliche/r
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Quantitative Drug Safety and Benefit Risk Evaluation
  • Produktbild: Quantitative Drug Safety and Benefit Risk Evaluation
  • 1 The Emergence of Aggregate Safety Assessment Across the Regulatory Landscape 2 Aggregate Safety Assessment Planning in Clinical Development 3 Safety Signaling and Causal Evaluation 4 Safety Monitoring through External Committees 5 An Overview on Statistical Methodologies for Safety Monitoring and Benefit-Risk Assessment 6 Quantitative Methods for Blinded Safety Monitoring 7 Bayesian Safety Methodology 8 Likelihood-Based Methods for Safety Monitoring 9 Meta-Analysis for Drug Safety Assessment 10 Design consideration for pragmatic trials with insight from cardiovascular outcome trials 11 Post-market Safety Assessment Using Observational Studies and the FDA Sentinel System 12 Analysis Considerations for Real-World Evidence and Clinical Trials Related to Safety 13 Trends and Recent Progress in Benefit-Risk Assessment Planning for Medical Products and Devices 14 Estimands in Safety and Benefit Risk Evaluation 15 Visual Analytics for Safety and Benefit Risk Evaluation